Raymond James Trust N.A. lessened its position in shares of Steris PLC (NYSE:STE) by 10.5% during the 1st quarter, HoldingsChannel reports. The firm owned 2,586 shares of the medical equipment provider’s stock after selling 304 shares during the quarter. Raymond James Trust N.A.’s holdings in Steris were worth $331,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also recently made changes to their positions in STE. Oregon Public Employees Retirement Fund grew its holdings in shares of Steris by 10,585.0% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 3,572,743 shares of the medical equipment provider’s stock worth $33,000 after purchasing an additional 3,539,306 shares in the last quarter. Norges Bank acquired a new stake in Steris in the 4th quarter valued at $96,648,000. Federated Investors Inc. PA boosted its stake in Steris by 2,546.2% in the 3rd quarter. Federated Investors Inc. PA now owns 868,434 shares of the medical equipment provider’s stock valued at $99,348,000 after buying an additional 835,616 shares in the last quarter. BlackRock Inc. boosted its stake in Steris by 10.3% in the 4th quarter. BlackRock Inc. now owns 8,549,361 shares of the medical equipment provider’s stock valued at $913,498,000 after buying an additional 800,900 shares in the last quarter. Finally, Villere ST Denis J & Co. LLC acquired a new stake in Steris in the 4th quarter valued at $63,124,000. 88.03% of the stock is currently owned by institutional investors.
Shares of STE stock opened at $122.83 on Friday. The company has a current ratio of 2.56, a quick ratio of 1.99 and a debt-to-equity ratio of 0.40. The firm has a market capitalization of $10.39 billion, a P/E ratio of 26.70 and a beta of 1.08. Steris PLC has a one year low of $93.50 and a one year high of $129.87.
Several analysts recently commented on the company. Zacks Investment Research raised Steris from a “sell” rating to a “hold” rating in a research note on Thursday, March 28th. Stephens reaffirmed a “buy” rating and issued a $135.00 price target on shares of Steris in a research note on Thursday, February 14th. Finally, JMP Securities reaffirmed a “buy” rating and issued a $135.00 price target on shares of Steris in a research note on Thursday, February 14th. One equities research analyst has rated the stock with a sell rating and four have issued a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $138.20.
In other Steris news, CEO Walter M. Rosebrough, Jr. sold 50,000 shares of the business’s stock in a transaction on Thursday, March 21st. The stock was sold at an average price of $125.00, for a total value of $6,250,000.00. Following the transaction, the chief executive officer now owns 98,895 shares of the company’s stock, valued at $12,361,875. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, VP John Adam Zangerle sold 3,000 shares of the business’s stock in a transaction on Friday, January 25th. The stock was sold at an average price of $115.00, for a total value of $345,000.00. Following the completion of the transaction, the vice president now directly owns 33,796 shares in the company, valued at approximately $3,886,540. The disclosure for this sale can be found here. In the last three months, insiders sold 58,646 shares of company stock worth $7,284,093. Insiders own 2.38% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece was reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at https://www.baseballdailydigest.com/news/2019/04/21/raymond-james-trust-n-a-sells-304-shares-of-steris-plc-ste.html.
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
See Also: How Does the Quiet Period Work?
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.